ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,000 | -76.0% | 16,000 | -79.1% | 0.00% | – |
| Q1 2022 | $100,000 | -62.8% | 76,637 | -50.0% | 0.00% | – |
| Q4 2021 | $269,000 | -44.8% | 153,337 | -31.8% | 0.00% | -100.0% |
| Q3 2021 | $487,000 | -38.1% | 224,790 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $787,000 | -0.4% | 225,318 | +180.9% | 0.00% | 0.0% |
| Q1 2021 | $790,000 | -9.1% | 80,227 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $869,000 | -28.2% | 80,227 | -31.9% | 0.00% | -33.3% |
| Q3 2020 | $1,211,000 | +37.1% | 117,861 | +177.8% | 0.00% | +50.0% |
| Q2 2020 | $883,000 | +203.4% | 42,425 | +42.3% | 0.00% | +100.0% |
| Q1 2020 | $291,000 | +164.5% | 29,813 | +44.0% | 0.00% | – |
| Q2 2018 | $110,000 | -16.7% | 20,700 | -8.8% | 0.00% | – |
| Q1 2018 | $132,000 | -31.6% | 22,700 | -57.7% | 0.00% | – |
| Q4 2017 | $193,000 | -19.9% | 53,657 | -18.7% | 0.00% | – |
| Q3 2017 | $241,000 | – | 65,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |